Pfizer Inc. et al v. Natco Pharma, Inc. et al
Pfizer Inc., Warner-Lambert Company LLC and PF PRISM IMB B.V. |
Natco Pharma, Inc. and Natco Pharma, Ltd. |
1:2021cv01179 |
August 16, 2021 |
U.S. District Court for the District of Delaware |
Colm F Connolly |
Patent - Abbreviated New Drug Application(ANDA) |
35 U.S.C. § 271 |
None |
Docket Report
This docket was last retrieved on October 14, 2021. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 18 MOTION for Pro Hac Vice Appearance of Attorney David I. Berl, Christopher J. Mandernach, Michael Xun Liu, Seth R. Bowers, Andrew Hoffman and Kevin Hoagland-Hanson - filed by PF Prism IMB B.V., Pfizer Inc., Warner-Lambert Company LLC, Pfizer Inc.. (Dellinger, Megan) |
![]() |
Pro Hac Vice Attorneys Karen L. Beckman, B. Jefferson Boggs, Jr, Andrew O. Larsen, and Christopher J. Sorenson for Natco Pharma, Inc. and Natco Pharma, Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs) |
Filing 17 MOTION for Pro Hac Vice Appearance of Attorney B. Jefferson Boggs, Christopher J. Sorenson, Karen L. Beckman and Andrew O. Larsen - filed by Natco Pharma, Inc., Natco Pharma, Ltd.. (Farnan, Kelly) |
Filing 16 NOTICE OF SERVICE of (1) Defendants Natco Pharma, Inc. and Natco Pharma, Ltd.s Initial Disclosures Under Fed. R. Civ. P. 26(a)(1) and (2) Defendants Natco Pharma, Inc. and Natco Pharma, Ltd.s Initial Disclosures Pursuant to the Delaware Default Standard Paragraph 3 filed by Natco Pharma, Inc., Natco Pharma, Ltd..(Farnan, Kelly) |
Filing 15 STIPULATION to Enter Protective Order by PF PRISM IMB B.V., Pfizer Inc., Warner-Lambert Company LLC. (Attachments: #1 Exhibit 1)(Dellinger, Megan) |
![]() |
Filing 14 NOTICE OF SERVICE of (1) Plaintiffs' Initial Disclosures Under Fed. R. Civ. P. 26(a)(1); and (2) Plaintiffs' Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by PF PRISM IMB B.V., Pfizer Inc., Warner-Lambert Company LLC.(Dellinger, Megan) |
![]() |
![]() |
CASE REFERRED to Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at # https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf Associated Cases: 1:21-cv-01179-CFC, 1:19-md-02912-CFC(Taylor, Daniel) |
Filing 12 PROPOSED ORDER Scheduling Order by PF PRISM IMB B.V., Pfizer Inc., Warner-Lambert Company LLC. (Attachments: #1 Cover Letter)(Dellinger, Megan) |
Filing 11 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Natco Pharma Inc. for Natco Pharma, Ltd. filed by Natco Pharma, Inc., Natco Pharma, Ltd.. (Farnan, Kelly) |
Filing 10 ANSWER to #1 Complaint, by Natco Pharma, Inc., Natco Pharma, Ltd..(Farnan, Kelly) |
Filing 9 Letter to The Honorable Colm F. Connolly from Megan E. Dellinger regarding cases in MDL No. 19-2912. (Dellinger, Megan) |
Filing 8 WAIVER OF SERVICE returned executed by Warner-Lambert Company LLC, Pfizer Inc., PF PRISM IMB B.V.: For Natco Pharma, Ltd. waiver sent on 8/18/2021, answer due 10/18/2021. (Dellinger, Megan) |
Filing 7 WAIVER OF SERVICE returned executed by Warner-Lambert Company LLC, Pfizer Inc., PF PRISM IMB B.V.: For Natco Pharma, Inc. waiver sent on 8/18/2021, answer due 10/18/2021. (Dellinger, Megan) |
Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
Filing 6 Summons Issued with Magistrate Consent Notice attached as to Natco Pharma, Inc. on 8/17/2021; Natco Pharma, Ltd. on 8/17/2021. (Attachments: #1 Summons Issued)(myr) |
Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc. for PF PRISM IMB B.V., Warner-Lambert Company LLC. Pfizer Inc. has no parent corporation filed by PF PRISM IMB B.V., Pfizer Inc., Warner-Lambert Company LLC. (myr) |
Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE47,739 E ;10,723,730 B2. (myr) |
Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No Earlier than July 14, 2021. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 1/14/2024. (myr) |
Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr) |
Filing 1 COMPLAINT filed against Natco Pharma, Inc., Natco Pharma, Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3679610.) - filed by Warner-Lambert Company LLC, Pfizer Inc., PF PRISM IMB B.V. (Attachments: #1 Exhibit A-B, #2 Civil Cover Sheet)(myr) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.